Esco Lifesciences’ US$200 Million Series A Financing

Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here